Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research
Shridevi Institute of Medical Sciences in Tumakuru has signed an MoU with Vaxonyx LLC for collaboration. This partnership aims to focus on AI-enabled bioinformatics and genomic research tailored for Indian populations. They will develop personalized cancer therapies by analyzing individual tumor profiles. The collaboration will also explore the creation of genomic datasets to improve genetic models. Moreover, they intend to develop DNA-based vaccine candidates for relevant public health issues.
RSS News
Economic times
0 thoughts on “Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Madhoo backs Rashmika Mandanna over South Indian accent criticism; says ‘own it, girl’
- Ayushmann Khurrana about an early rejection story involving Karan Johar
- Saiee M Manjrekar’s look from Ram Charan-backed ‘The India House’ leaks
- Kamal reveals how Mammootty’s joke led to ‘Mazhayethum Munpe’
- Student sets mehndi record in Karnataka
